Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Our purpose in this study is to evaluate the clinical feasibility of deep-learning techniques for F-18 florbetaben (FBB) positron emission tomography (PET) image reconstruction using data acquired in a short time. We reconstructed raw FBB PET data of 294 patients acquired for 20 and 2Â min into standard-time scanning PET (PET) and short-time scanning PET (PET) images. We generated a standard-time s...
It is challenging to compare amyloid PET images obtained with different radiotracers. Here, we introduce a new approach to improve the interchangeability of amyloid PET acquired with different radiotracers through image-level translation. Deep generative networks were developed using unpaired PET datasets, consisting of 203 [C]PIB and 850 [F]florbetapir brain PET images. Using 15 paired PET datase...
BACKGROUND: d-glutamate, which is involved in N-methyl-d-aspartate receptor modulation, may be associated with cognitive ageing.
Clinical trials of novel therapeutics for Alzheimer's Disease (AD) have consumed a large amount of time and resources with largely negative results. R...
PURPOSE: Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disease. In recent years, machine learning methods have been wid...
Alzheimer's disease is the most prevalent dementia among the elderly population. Early detection is critical because it can help with future planning ...
. At present, the research methods for image genetics of Alzheimer's disease based on machine learning are mainly divided into three steps: the first ...
PURPOSE: The accuracy of existing PET/MR attenuation correction (AC) has been limited by a lack of correlation between MR signal and tissue electron d...
BACKGROUND: Psychosocial health issues such as depression and social isolation are an important cause of morbidity and premature mortality for older a...
Recent studies have confirmed that white matter hyperintensities (WMHs) accumulated in strategic brain regions can predict cognitive impairments assoc...
Alzheimer's disease (AD) is the most common type of dementia. Its diagnosis and progression detection have been intensively studied. Nevertheless, res...
Despite the increasing incidence and high morbidity associated with dementia, a simple, non-invasive, and inexpensive method of screening for dementia...
Early identification of degenerative processes in the human brain is considered essential for providing proper care and treatment. This may involve de...
The concept of Mild Cognitive Impairment (MCI) is used to describe the early stages of Alzheimer's disease (AD), and identification and treatment befo...
INTRODUCTION: Machine learning models were used to discover novel disease trajectories for autosomal dominant Alzheimer's disease.
PURPOSE: While sampled or short-frame realizations have shown the potential power of deep learning to reduce radiation dose for PET images, evidence i...
Alzheimer's disease is the leading cause of dementia. The long progression period in Alzheimer's disease provides a possibility for patients to get ea...
PURPOSE: Standardized uptake value ratio (SUVr) used to quantify amyloid-β burden from amyloid-PET scans can be biased by variations in the tracer's n...
Alzheimer's disease (AD) is the most prevalent neurodegenerative disease causing dementia and poses significant health risks to middle-aged and elderl...
BACKGROUND: Alzheimer's disease (AD) is the most common type of dementia, typically characterized by memory loss followed by progressive cognitive dec...